Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0609-2025

Drug recall · September 10, 2025

Semaglutide recall

Why: Subpotent Drug

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

Lots / codes

03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025

Quantity
648 vials
Company
Boothwyn Pharmacy LLC, Kennett Square, PA
Distribution
U.S. Nationwide
Initiated
July 9, 2025 · Voluntary: Firm initiated
Classified
August 29, 2025
Reported
September 10, 2025
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.